ALCAM and myeloid sarcoma: Interestingly, in vitro studies show increased CD166/ALCAM transcriptional activity for the rs6437585T allele [82], which would agree with investigations showing upregulated CD166/ALCAM expression on central nervous system vessels in active MS lesions [39].